Skip to content

Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).

Clinical Feasibility Study of Upright, Low-dose, High-resolution, 3D Breast CT (UBCT).

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07705100
Acronym
UBCT
Enrollment
50
Registered
2026-07-15
Start date
2026-08-01
Completion date
2026-12-31
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Detection

Brief summary

The investigators are doing this study to find out if a new kind of breast imaging (called upright dedicated breast CT or UBCT) can help doctors to see the small structures in breast tissue more clearly in 3-D and without overlap. The breast imaging device that will be used in this study (UBCT) is not FDA-approved, so this is a research study. The machine has been designed to remove mammography-like breast compression and use radiation dose comparable to mammography. The breast CT device will take multiple x-ray pictures of the subjects breast in approximately 20 seconds and create a 3-D image of the breast. It does not compress or squish the breast like a mammogram.

Interventions

DEVICELow dose, upright, dedicated breast CT

This study investigates the feasibility of an upright, dedicated breast CT (UBCT) for breast cancer detection.

Sponsors

University of Arizona
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

For the screening cohort, the inclusion criteria are, women: * (1) who were 40 years of age or older (typical screening age range), and, * (2) who were asymptomatic, and, * (3) who underwent or scheduled to undergo a standard-of-care 2-view bilateral digital breast tomosynthesis screening exam. For the diagnostic cohort, the inclusion criteria are, women: * (1) who were 40 years of age or older, and, * (2) who underwent a standard-of-care 2-view bilateral digital breast tomosynthesis exam, and, * (3) who were assigned BI-RADS category 4 or 5 after diagnostic work-up and are scheduled for biopsy.

Exclusion criteria

* Males * Women less than 40 years old * pregnant or lactating women * women with physical limitations (e.g., kyphosis) that may prohibit UBCT exam * women who have received radiation treatments to the thorax * women who have participated in a prior breast clinical trial that gave additional radiation dose * women who have received large numbers of diagnostic x-ray examinations for monitoring of disease such as tuberculosis, and severe scoliosis.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of UBCTFrom enrollment to end of study in approximately 6 months.The proportion of participants who successfully complete the imaging exam using upright, dedicated breast CT (UBCT).

Contacts

CONTACTMichele N Galvan, R.T.
mngalvan@arizona.edu520-626-2279
PRINCIPAL_INVESTIGATORSrinivasan Vedantham, PhD

University of Arizona

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026